Conversion therapy of stage IVb unresectable gallbladder carcinoma.
作者信息
Ning Cong, Zhang Xinmu, Yang Xiaobo, Sang Xinting, Zhao Haitao, Wang Hanping
机构信息
Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
出版信息
Hepatobiliary Surg Nutr. 2022 Apr;11(2):335-337. doi: 10.21037/hbsn-22-78.
Abstract
摘要
相似文献
1
Conversion therapy of stage IVb unresectable gallbladder carcinoma.
Hepatobiliary Surg Nutr. 2022 Apr;11(2):335-337. doi: 10.21037/hbsn-22-78.
2
The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series.
J Otolaryngol Head Neck Surg. 2018 Oct 16;47(1):62. doi: 10.1186/s40463-018-0310-y.
3
[Successful curative resection after chemotherapy for initially unresectable advanced gallbladder cancer with rectal metastasis:a case report].
Nihon Shokakibyo Gakkai Zasshi. 2018;115(10):905-913. doi: 10.11405/nisshoshi.115.905.
4
Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report.
Surg Case Rep. 2022 Mar 25;8(1):50. doi: 10.1186/s40792-022-01406-9.
5
Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study.
Surgery. 2021 Jun;169(6):1304-1311. doi: 10.1016/j.surg.2020.12.039. Epub 2021 Feb 5.
6
Patterns of Presentation, Treatment, and Survival Rates of Gallbladder Cancer: a Prospective Study at a Tertiary Care Centre.
J Gastrointest Cancer. 2018 Sep;49(3):268-274. doi: 10.1007/s12029-017-9940-y.
7
[Surgical therapy of gallbladder cancer].
Chirurg. 1988 Apr;59(4):236-43.
8
Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report.
Surg Case Rep. 2022 Jan 26;8(1):20. doi: 10.1186/s40792-022-01375-z.
9
Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
J Am Coll Surg. 2001 May;192(5):600-7. doi: 10.1016/s1072-7515(01)00814-6.
10
Radical operations for carcinoma of the gallbladder: present status in Germany.
World J Surg. 1991 May-Jun;15(3):328-36. doi: 10.1007/BF01658724.
引用本文的文献
1
Hepatic arterial infusion chemotherapy combined with bevacizumab plus a PD-1 inhibitor for gallbladder cancer with hepatic oligometastasis: a real-world study.
J Gastrointest Oncol. 2024 Feb 29;15(1):330-345. doi: 10.21037/jgo-23-816. Epub 2024 Feb 28.
2
Chemotherapy combined with targeted therapy and immunotherapy is an option in advanced biliary tract cancer.
Therap Adv Gastroenterol. 2024 Feb 26;17:17562848241234509. doi: 10.1177/17562848241234509. eCollection 2024.
3
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
BMC Med. 2024 Jan 29;22(1):42. doi: 10.1186/s12916-024-03257-7.
本文引用的文献
1
Interpretation of NCCN guidelines for hepatobiliary tumors V3 update in 2021.
Hepatobiliary Surg Nutr. 2021 Oct;10(5):682-685. doi: 10.21037/hbsn-21-355.
2
Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy.
Hepatobiliary Surg Nutr. 2021 Aug;10(4):434-442. doi: 10.21037/hbsn-21-188.
3
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma.
Hepatobiliary Surg Nutr. 2020 Aug;9(4):414-424. doi: 10.21037/hbsn-20-338.
4
Modern therapeutic approaches for the treatment of malignant liver tumours.
Nat Rev Gastroenterol Hepatol. 2020 Dec;17(12):755-772. doi: 10.1038/s41575-020-0314-8. Epub 2020 Jul 17.
5
Nutritional support treatment for perioperative patients in hepatobiliary surgery.
Hepatobiliary Surg Nutr. 2020 Jun;9(3):342-344. doi: 10.21037/hbsn.2019.10.27.
6
Immunotherapy in hepatobiliary tumors: search for the missing pieces of the puzzle.
Hepatobiliary Surg Nutr. 2020 Feb;9(1):86-88. doi: 10.21037/hbsn.2019.10.33.
7
Gallbladder cancer: epidemiology and outcome.
Clin Epidemiol. 2014 Mar 7;6:99-109. doi: 10.2147/CLEP.S37357. eCollection 2014.
8
A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer.
Gut Liver. 2013 Sep;7(5):594-8. doi: 10.5009/gnl.2013.7.5.594. Epub 2013 Jun 11.
9
The place of downstaging for hepatocellular carcinoma.
J Hepatol. 2010 Jun;52(6):930-6. doi: 10.1016/j.jhep.2009.12.032. Epub 2010 Mar 15.
10
Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based?
J Clin Oncol. 2008 Apr 10;26(11):1786-8. doi: 10.1200/JCO.2007.15.6380.
Zotero 插件